Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Ohta

Showing results (21-30 of 145) with videos related to

Pageof 15
Sort By:
Advanced Drug Delivery Reviews|December 21, 2007
PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymesSadamitsu Asoh, Shigeo Ohta
Seikagaku. the Journal of Japanese Biochemical Society|September 7, 2004
[Protein transduction and protection of cells against apoptosis]Sadamitsu Asoh, Shigeo Ohta
Canadian Journal of Physiology and Pharmacology|September 29, 2021
Reply to "Discussion: Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study"Shigeo Ohta, Tyler W LeBaron
Medical Gas Research|December 8, 2011
The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas ResearchShigeo Ohta, Atsunori Nakao, Kinji Ohno
Biochemical and Biophysical Research Communications|January 27, 2004
Green fluorescent protein causes mitochondria to aggregate in the presence of the Bcl-2 family proteinsToshiyuki Aokage, Ikuroh Ohsawa, Shigeo Ohta
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|June 9, 2005
Aggregation of mitochondriaToshiyuki Aokage, Ikuroh Ohsawa, Shigeo Ohta
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 28, 2005
Various morphologies of mitochondriaIkuroh Ohsawa, Toshiyuki Aokage, Shigeo Ohta
Thescientificworldjournal|August 28, 2018
The Super Anti-Apoptotic Factor Bcl-xFNK: A Novel Mutant of Rat Bcl-Xl with a Gain-of-Function PhenotypeSadamitsu Asoh, Takashi Ohtsu, Shigeo Ohta
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Therapeutic Inhalation of Hydrogen Gas for Alzheimer's Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot StudyHirohisa Ono, Yoji Nishijima, Shigeo Ohta
Medical Gas Research|October 7, 2022
Discovery of a hydrogen molecular targetXuejun Sun, Shigeo Ohta, John H Zhang
Pageof 15

Showing results (21-30 of 145) with videos related to

Sort By:
Pageof 15
Advanced Drug Delivery Reviews|December 21, 2007
PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymesSadamitsu Asoh, Shigeo Ohta
Seikagaku. the Journal of Japanese Biochemical Society|September 7, 2004
[Protein transduction and protection of cells against apoptosis]Sadamitsu Asoh, Shigeo Ohta
Canadian Journal of Physiology and Pharmacology|September 29, 2021
Reply to "Discussion: Drinking hydrogen water enhances endurance and relieves psychometric fatigue: a randomized, double-blind, placebo-controlled study"Shigeo Ohta, Tyler W LeBaron
Medical Gas Research|December 8, 2011
The 2011 Medical Molecular Hydrogen Symposium: An inaugural symposium of the journal Medical Gas ResearchShigeo Ohta, Atsunori Nakao, Kinji Ohno
Biochemical and Biophysical Research Communications|January 27, 2004
Green fluorescent protein causes mitochondria to aggregate in the presence of the Bcl-2 family proteinsToshiyuki Aokage, Ikuroh Ohsawa, Shigeo Ohta
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|June 9, 2005
Aggregation of mitochondriaToshiyuki Aokage, Ikuroh Ohsawa, Shigeo Ohta
Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|July 28, 2005
Various morphologies of mitochondriaIkuroh Ohsawa, Toshiyuki Aokage, Shigeo Ohta
Thescientificworldjournal|August 28, 2018
The Super Anti-Apoptotic Factor Bcl-xFNK: A Novel Mutant of Rat Bcl-Xl with a Gain-of-Function PhenotypeSadamitsu Asoh, Takashi Ohtsu, Shigeo Ohta
Pharmaceuticals (Basel, Switzerland)|March 29, 2023
Therapeutic Inhalation of Hydrogen Gas for Alzheimer's Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot StudyHirohisa Ono, Yoji Nishijima, Shigeo Ohta
Medical Gas Research|October 7, 2022
Discovery of a hydrogen molecular targetXuejun Sun, Shigeo Ohta, John H Zhang
Pageof 15